Friday, November 6, 2026

Back to the front page

From X

@StableBread 4 clicks

Fajasy on X

Here’s where BWX Technologies’ $BWXT stock could be by the end of 2027, 15 months from now, in my bear, base, and bull cases. I value each case on 2028 adjusted EBITDA, since the market will be pricing 2028 numbers by then. For net debt, I use today’s $1.65B minus the $750M from its medical isotope sale, or $0.9B. To stay conservative, I don’t credit the FCF $BWXT earns between now and the end of 2027. Management plans to spend the cash, including on acquisitions, but hasn’t said how much or on what, so I leave out both the cash and any EBITDA acquisitions could potentially add. Therefore, each case’s value is 2028 adjusted EBITDA times the multiple, minus the $0.9B of net debt, over 92.0M diluted shares (its convertible notes only dilute above $262.51). Bear case ($118, -19%) The bear case assumes budgets slip (the government is running on a continuing resolution through December 11), the terms of its Janus contract (the Army’s microreactor program for military bases) disappoint, and new-build orders arrive later than John MacQuarrie, president of Commercial Operations, expects. That implies only 5%/year adjusted EBITDA growth to $735M in 2028, and a multiple of 16x, slightly below $BWXT’s 16.6x at the end of 2023, for a value of $118/share. Base case ($162, +11%, most likely) The base case assumes $BWXT delivers its 2027 framework (high-single-digit growth to $720M of adjusted EBITDA) and grows 10% in 2028 to $790M as new-build revenue starts. That implies the multiple holds at 20x, near today’s, for a value of $162/share. $BWXT’s own 2030 plan goes further. Today’s $15.0B EV is 13.0x the $1.15B midpoint of its 2030 adjusted EBITDA target. If $BWXT hits that midpoint, trades at 18x instead of the base case’s 20x, and runs at 2.5x net leverage (~$2.9B of net debt) after deploying its capital, the stock would be worth $194/share at the end of 2029. With ~$4/share of total dividends through 2029, that’s a 9.9%/year return from $145.70. But getting from the base case’s $790M in 2028 to $1.15B in 2030 takes ~21%/year growth, more than double the 2028 pace, so the new orders and acquisitions outside $BWXT’s predictable core (the programs backed by backlog and long-term contracts) have to show up. Bull case ($204, +40%) The bull case assumes a new-build order lands by early 2027, $BWXT signs a Janus contract on par with microreactor startup Radiant’s (up to $750M), and margins rise toward 20%. That implies adjusted EBITDA of $820M in 2028 and a re-rating to 24x, just under the 24.8x of Curtiss-Wright $CW today, for a value of $204/share. Notably, none of the three cases considers a commercial BANR (microreactor) sale, a Wyoming TRISO fuel plant, a battleship reactor, or a data center customer, so at $145.70/share, you’re getting commercial microreactors and data centers as a free option.
@convequity

Convequity on X

Neoclouds Now Trade as a Hedge Against AI Demand Growth Convequity’s latest ABBX review shows $CRWV, $NBIS and $IREN are inversely correlated with AI demand growth. Stronger demand widens the working-capital hole and keeps investors risk-off, even as order books expand. Insatiable demand is usually the reason to own the supplier. Here it does the opposite. Jensen Huang told CNBC at GTC Berlin that neocloud demand is “off the charts” and that working capital is the missing piece. Working capital is current assets minus current liabilities. A cash-conversion mismatch squeezes it even when demand is huge. Liabilities hit first. A neocloud pays $NVDA and networking suppliers in roughly 30–60 days. Asset-backed hardware loans add heavy near-term debt service. Assets lag. A signed customer contract sits off the balance sheet as backlog. It only becomes receivables or cash once the cluster is deployed, energized and billed — months later. Cash leaves before revenue arrives. A faster pipeline simply widens the short-term deficit. Latest ABBX figures NBIS: $8.5B gross debt vs $8.0B cash; guidance for >$9B customer prepayments this year. IREN: $7.6B debt vs $5.9B cash; $13.8B hardware and site commitments; 20% prepay on the Microsoft contract. CRWV: $35.6B debt vs $5.5B cash, plus $16.3B operating leases and $35.5B rent not yet commenced. Build-out relies far more on debt than customer prepayments. Even with those prepayments, NBIS and IREN keep raising large extra funding. CRWV faces the same hole with a far larger debt stock. Handing contracts back to resell at higher spot prices would ease CRWV’s cash hole only if customers and lenders agreed. Customers pay even if they do not use the capacity, CRWV must deliver it, and we found no public right to change the price or exit early. Break a customer contract and the hardware lenders can lock up CRWV’s cash. If that lockup holds, they take the cash to repay the loan. Borrowing later would cost more, and the switch only pays while spot stays high. If spot fell, CRWV would lose both the committed revenue and the contract value backing those loans. For investors to turn risk-on again, AI demand growth needs to slow enough for infrastructure supply to catch up.

Trading Post November 5, 2026

MercadoLibre’s logistics expansion cut margins by 60 basis points, while Mercado Pago grew credit 62% with 7% NPLs.

Thursday Tailwinds #13: Nov 5, 2026

Florida marinas are 92% full as boat counts rise and permits constrain new supply, creating pricing power for existing operators such as…

New Ideas From The Road

Aurelion Research increased healthcare exposure and sees opportunities in banking and defense, alongside research on Alcoa, Nike, ONON and…

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

X accounts we follow

Every account on this site, hand-picked.

91 accounts

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.